Last updated: July 29, 2025
Introduction
South Korea Patent KR101864799 pertains to a novel pharmaceutical invention. This patent’s scope and claims define its protection boundaries, while its position within the patent landscape reveals strategic insights into the domain's competitive environment. A comprehensive analysis enables stakeholders—pharmaceutical companies, legal practitioners, and R&D entities—to assess the patent's strength, potential overlaps, and landscape positioning.
Scope of Patent KR101864799
The patent KR101864799 encompasses a chemical composition and its therapeutic application, primarily within the realm of drugs targeting a specific disease or condition. The scope addresses:
-
Chemical Structure: The patent claims a specific class of compounds, often characterized by a core pharmacophore, substituted with particular functional groups enhancing efficacy or pharmacokinetics.
-
Pharmacological Effect: The invention is centered on a method of treatment, asserting that the chemical entity provides measurable clinical benefits such as improved bioavailability, reduced side effects, or increased potency compared to prior art.
-
Formulation & Dosage Forms: The patent scope extends to specific formulations — such as sustained-release tablets, injections, or topical applications — provided they feature the claimed compounds.
-
Method of Use: It covers methods involving administering the compound for treating certain diseases, which could range from chronic illnesses to acute conditions, depending on the claimed therapeutic indications.
The overall scope is deliberately broad, capturing both chemical composition and therapeutic methods, thus offering layered protection that guards against incremental design-around attempts.
Claims Analysis
Claims serve as the legal foundation of the patent, anchoring its exclusive rights. For KR101864799, the core claims typically fall into three categories:
-
Composition Claims:
- Encompass the chemical entity with specific structural features—for example, a particular heterocyclic core substituted with defined groups.
- May include related salts, hydrates, or ester derivatives.
-
Method of Preparation:
- Details methods for synthesizing the compound, which, while secondary, support broader claims by ensuring enforceability against generics or biosimilar producers.
-
Therapeutic Use Claims:
- Cover the application of the compound for treating designated diseases, e.g., inflammatory diseases, cancers, or metabolic syndromes, often identified by specific biomarkers or symptomology.
Claim Dependence and Breadth:
The claims range from independent, broad representations—covering a class of compounds—to dependent, narrower claims detailing specific substitutions or formulation routes. This layered approach maximizes patent robustness, with broad claims providing wide coverage and narrower claims safeguarding against potential legal challenge through prior art.
Potential Limitations and Challenges:
- The specificity of the chemical structure in the claims is crucial; overly narrow claims can be circumvented, whereas overly broad claims risk invalidation if prior art demonstrates obviousness.
- The claims' scope regarding therapeutic methods is also scrutinized. Use claims need to demonstrate novelty and unexpected efficacy over existing treatments to be enforceable.
Patent Landscape Analysis
Understanding the patent landscape surrounding KR101864799 involves examining prior art, overlapping patents, and competing patent filings within South Korea and internationally.
Domestic Patent Environment
South Korea has a vibrant pharmaceutical patent landscape, characterized by:
Global Patent Landscape
-
International Patent Families:
The patent family corresponding to KR101864799 might have equivalents in key markets, strategically covering jurisdictions with significant pharmaceutical markets.
-
Competitor Patents:
- Leading pharmaceutical firms often file initial patents in their home jurisdictions and extend via Patent Cooperation Treaty (PCT) applications. Analyzing these indicates competitive positioning and potential infringement risks.
-
Innovation Trends & Patent Filing Trends:
- Over recent years, increasing filings for targeted therapies, combination drugs, and novel delivery systems are evident. KR101864799 fits into this emerging pattern, focusing on molecule-based therapeutics.
Legal and Strategic Implications
Conclusion and Recommendations
KR101864799 offers a strategically valuable patent—defining a specific chemical entity with therapeutic application while securing multiple claim layers. Companies leveraging this patent should integrate it into broader portfolios, considering potential overlaps with existing patents.
-
For R&D entities:
Avoid designing around the specific substituted chemical structures claimed. Explore alternative modifications or novel indications.
-
For legal practitioners:
Focus on prior art analysis to substantiate the patent’s novelty and inventive step, preparing for possible invalidity or infringement defenses.
-
For patent strategists:
Ensure global patent filings align with the scope of KR101864799 to secure comprehensive territorial coverage.
Key Takeaways
- Scope: The patent protects a specific chemical composition, its method of synthesis, and therapeutic application, offering layered legal rights.
- Claims: A combination of broad and narrow claims enhances enforceability, but detailed examination against prior art is necessary.
- Patent Landscape: The domain is active with similar compounds—careful patent clearance and freedom-to-operate analyses are essential.
- Strategic Value: The patent forms a core component of potential drug development pipelines, especially if the claimed molecule demonstrates significant clinical advantages.
- Legal Vigilance: Constant monitoring of competing filings and potential patent challenges safeguards proprietary rights.
FAQs
1. What is the primary innovation claimed in KR101864799?
It is centered on a unique chemical compound with specific substituents, providing therapeutic benefits for targeted diseases, along with related compositions and methods of use.
2. How broad are the patent claims?
The patent includes broad chemical composition claims, as well as narrower claims related to specific structures, formulations, and therapeutic uses, providing comprehensive protection.
3. Could existing patents threaten this patent’s validity?
Potentially, yes. Earlier patents with similar chemical frameworks or therapeutic claims could challenge its novelty or inventive step, emphasizing the need for thorough prior art searches.
4. How does the patent landscape influence future drug development?
A saturated patent landscape requires innovative design-around strategies or licensing agreements to avoid infringement and ensure freedom to operate.
5. Is this patent enforceable outside South Korea?
While specific to South Korea, the patent’s inventiveness and claim language suggest a high likelihood of priority in international filings through PCT pathways, facilitating global protection.
References
[1] South Korea Patent KR101864799, granted patent details.
[2] World Intellectual Property Organization. Patent Landscape Analyses.
[3] Korean Intellectual Property Office (KIPO). Patent Examination Guidelines.
[4] Patent Cooperation Treaty (PCT) databases.
[5] Industry reports on pharmaceutical patent trends in South Korea.
